Ligand validation:5DUS

APR: ADENOSINE-5-DIPHOSPHORIBOSE

APR is a Ligand Of Interest in 5DUS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5DUS_APR_A_201	96%	4%	0.07	0.979	4.23	1.58	11	6	0	0	100%	1
5HOL_APR_A_201	88%	21%	0.09	0.967	1.73	1.6	7	8	1	0	100%	1
8YN0_APR_A_701	100%	40%	0.032	0.995	0.72	1.6	-	6	1	0	97%	0.95
2FAV_APR_B_477	100%	36%	0.038	0.985	0.92	1.58	2	5	0	1	100%	0.97
9QYF_APR_A_501	100%	39%	0.041	0.985	0.76	1.6	1	1	0	0	100%	0.5
9YHL_APR_B_201	100%	4%	0.043	0.986	4.31	1.33	14	5	0	0	100%	0.56
9YHH_APR_A_201	99%	5%	0.047	0.986	4.04	1.48	13	5	0	0	100%	0.82

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.